Vanda Pharmaceuticals (VNDA) Research & Development (2016 - 2025)
Historic Research & Development for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q4 2025 value amounting to $29.0 million.
- Vanda Pharmaceuticals' Research & Development rose 4619.96% to $29.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $109.3 million, marking a year-over-year increase of 4680.85%. This contributed to the annual value of $109.3 million for FY2025, which is 4680.85% up from last year.
- Per Vanda Pharmaceuticals' latest filing, its Research & Development stood at $29.0 million for Q4 2025, which was up 4619.96% from $22.6 million recorded in Q3 2025.
- In the past 5 years, Vanda Pharmaceuticals' Research & Development registered a high of $35.7 million during Q1 2025, and its lowest value of $16.1 million during Q1 2021.
- In the last 5 years, Vanda Pharmaceuticals' Research & Development had a median value of $20.0 million in 2021 and averaged $21.1 million.
- As far as peak fluctuations go, Vanda Pharmaceuticals' Research & Development plummeted by 3321.8% in 2023, and later skyrocketed by 6881.91% in 2025.
- Vanda Pharmaceuticals' Research & Development (Quarter) stood at $19.3 million in 2021, then dropped by 4.54% to $18.5 million in 2022, then soared by 31.89% to $24.3 million in 2023, then fell by 18.48% to $19.8 million in 2024, then surged by 46.2% to $29.0 million in 2025.
- Its Research & Development was $29.0 million in Q4 2025, compared to $22.6 million in Q3 2025 and $22.0 million in Q2 2025.